Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device.
M
M
Igarashi
Y
Y
Abe
M
M
Fukuda
A
A
Ando
M
M
Miyasaka
M
M
Yoshida
O A
OA
Shawki
D018394:CA-125 Antigen / Q000097:blood; D003613:Danazol / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D004715:Endometriosis / Q000150:complications / Q000628:therapy*; D004717:Endometrium / Q000187:drug effects / Q000473:pathology; D004965:Estrogen Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000209:etiology / Q000628:therapy; D007436:Intrauterine Devices, Medicated; D008599:Menstruation Disturbances; D014591:Uterine Diseases / Q000150:complications / Q000628:therapy*
D018394:CA-125 Antigen; D004965:Estrogen Antagonists; D003613:Danazol